SEC Filing Summary

George Eric Davis, EVP, Chief Legal Officer at BIOMARIN PHARMACEUTICAL INC, reported transactions on March 16, 2026. He acquired 14,570 shares of Common Stock (transaction code A) at a price of $0.00, and disposed of 7,177 shares of Common Stock (transaction code F) at a price of $58.51 per share. Additionally, he was granted 34,690 stock options (transaction code A) with an exercise price of $57.43, vesting starting March 17, 2027. Post-transaction, his holdings in Common Stock amount to 79,833 shares, with a note indicating a correction to previous holdings.